TruDiagnostic™ parent purchases Dr. David Sinclair co-founded company to create world's largest epigenetic data platform

TruDiagnostic™母公司收购了David Sinclair博士共同创立的公司，以创建全球最大的表观遗传数据平台。

LEXINGTON, Ky.

肯塔基州列克星敦

,

，

April 29, 2026

2026年4月29日

/PRNewswire/ -- Infinite Epigenetics

/PRNewswire/ -- 无限表观遗传学

TM

商标

, a global leader in epigenetic science, biological age testing, and next-generation diagnostics, today announced the acquisition of

，一家在全球表观遗传学、生物年龄测试和下一代诊断领域处于领先地位的公司，今天宣布收购

Tally Health

Tally Health

®, a biotechnology company pioneering consumer-focused longevity solutions. Tally Health brings cutting-edge science closer to everyday life by helping people better understand how they're aging and what they can do about it.

®，一家开发生物科技公司，致力于消费者导向的长寿解决方案。Tally Health 通过帮助人们更好地了解自己的衰老过程以及可以采取的措施，将前沿科学带入日常生活。

Continue Reading

继续阅读

Tally Health Product Suite

Tally健康产品套件

The asset purchase, the largest in epigenetic age testing, brings together two category leaders to create a vertically integrated platform spanning advanced epigenetic diagnostics, the world's largest and most diverse private adult DNA methylation datasets, and personalized interventions, including longevity-focused supplements, designed to improve healthspan.

这项资产收购是表观遗传年龄检测领域最大的一笔交易，它将两个类别的领导者联合在一起，创建了一个垂直整合的平台，涵盖先进的表观遗传诊断、全球规模最大且最多样化的私人成人DNA甲基化数据集，以及包括专注于长寿的补充剂在内的个性化干预措施，旨在改善健康寿命。

By combining proprietary datasets with exclusively licensed, intellectual property originating from academia, the company is positioned to accelerate the development of next-generation diagnostics and interventions, and expand the role of epigenetics from research and lifestyle applications to mainstream healthcare..

通过将专有数据集与源自学术界的独家授权知识产权相结合，该公司有望加速下一代诊断和干预措施的开发，并将表观遗传学的作用从研究和生活方式应用扩展到主流医疗保健领域。

Following the transaction, Tally Health will remain a standalone consumer brand, preserving the trust, momentum, and brand equity it has built, while leveraging Infinite Epigenetics' scientific infrastructure, data scale, and diagnostic capabilities. Dr. Matthew Dawson will continue as CEO of Infinite Epigenetics and .

交易完成后，Tally Health将继续作为一个独立的消费品牌存在，保持其建立的信任、势头和品牌价值，同时利用Infinite Epigenetics的科学基础设施、数据规模和诊断能力。Matthew Dawson博士将继续担任Infinite Epigenetics的首席执行官。

TruDiagnostic

真诊断

, and Melanie Goldey will remain CEO of Tally Health, leading the consumer business. Together, the companies will focus on accelerating product innovation, expanding consumer access, and deepening the integration of diagnostics and personalized interventions.

，梅兰妮·戈尔迪将继续担任Tally Health的首席执行官，领导消费者业务。两家公司将共同致力于加速产品创新、扩大消费者获取渠道，并深化诊断和个性化干预的整合。

'We believe epigenetics will underpin the next generation of medical diagnostics, shifting healthcare from reactive treatment to proactive, data-driven prevention,' said Dr. Matthew Dawson, CEO of Infinite Epigenetics and TruDiagnostic. 'Our ambition is to build a category-defining diagnostics platform.

“我们相信表观遗传学将支撑下一代医疗诊断，推动医疗保健从被动治疗转向主动的、数据驱动的预防，”Infinite Epigenetics 和 TruDiagnostic 的首席执行官马修·道森博士说道。“我们的目标是打造一个定义类别的诊断平台。”

By combining our scientific infrastructure, proprietary data, and clinical capabilities with Tally Health's consumer reach, we can accelerate the adoption of epigenetics across healthcare – from research and clinical settings to population-scale applications.'.

通过将我们的科学基础设施、专有数据和临床能力与Tally Health的消费者覆盖范围相结合，我们可以加速表观遗传学在医疗保健领域的应用——从研究和临床环境到大规模人群的应用。

Infinite Epigenetics, through its subsidiary TruDiagnostic, has established itself at the forefront of epigenetic science with a CLIA-certified laboratory, proprietary analytical platforms, and flagship testing products TruAge

通过其子公司TruDiagnostic，Infinite Epigenetics凭借CLIA认证的实验室、专有分析平台和旗舰测试产品TruAge，已在表观遗传学领域确立了领先地位。

TM

商标

and TruHealth

和TruHealth

TM

商标符号 (™)

, which provide insights into epigenetic aging and system-level health. The science behind TruDiagnostic is powered by 115+ research partnerships with top institutions including Harvard, Yale, Duke, and Stanford. The purchase of Tally Health's assets represents a continued expansion of Infinite Epigenetics' portfolio, building a vertically integrated platform across diagnostics, data, and consumer health..

，这些资产提供了关于表观遗传衰老和系统级健康状况的深入见解。TruDiagnostic 背后的科学得到了与包括哈佛大学、耶鲁大学、杜克大学和斯坦福大学在内的顶级机构的 115 多个研究合作伙伴关系的支持。对 Tally Health 资产的收购代表了 Infinite Epigenetics 产品组合的持续扩展，构建了一个覆盖诊断、数据和消费者健康的垂直整合平台。

'From day one, Tally Health was built to take the most advanced science of aging and make it actionable for everyday people,' said Melanie Goldey, CEO of Tally Health. 'Joining Infinite Epigenetics allows us to dramatically accelerate that mission by combining best-in-class data, scientific rigor, and consumer experience to deliver a truly end-to-end longevity platform.

“从第一天起，Tally Health 就致力于将最前沿的衰老科学转化为每个人都能实践的行动，”Tally Health 首席执行官梅兰妮·戈尔德说。“加入 Infinite Epigenetics 使我们能够通过结合一流的数据、科学严谨性和消费者体验，大幅加速这一使命，从而提供一个真正的端到端长寿平台。”

Together, we have the opportunity to redefine how people engage with their health and aging.'.

我们有机会共同重新定义人们如何与他们的健康和衰老互动。

Tally Health complements Infinite Epigenetics' scientific foundation with a consumer platform designed to make longevity science accessible and actionable. Its offering is anchored by the TallyAge™ Test, a next-generation epigenetic age test delivered through a painless at-home cheek swab, alongside a suite of science-backed supplements and personalized recommendations targeting core drivers of aging.

Tally Health 通过一个旨在让长寿科学变得可及且可操作的消费者平台，补充了 Infinite Epigenetics 的科学基础。其核心产品是 TallyAge™ 测试，这是一种通过无痛的家庭颊拭子进行的下一代表观遗传年龄测试，并辅以一系列基于科学的补充剂和针对衰老核心驱动因素的个性化建议。

Co-founded by Dr. David Sinclair and Whitney Casey, and seeded by leading consumer-focused investment firm .

由大卫·辛克莱博士和惠特尼·凯西共同创立，并由领先的消费者导向投资公司提供种子资金。

L

L

Catterton, Tally Health has built a highly engaged consumer base by translating complex science into simple, everyday insights. The company also brings proprietary, exclusively licensed intellectual property, models, and datasets related to DNA methylation and longevity science.

凯特顿，Tally Health 通过将复杂的科学转化为简单、日常的见解，建立了高度参与的消费者群体。该公司还带来了与 DNA 甲基化和长寿科学相关的专有、独家授权的知识产权、模型和数据集。

'Epigenetics is one of the most powerful tools we have to understand the biological drivers of aging and disease,' said Dr. David Sinclair, co-founder of Tally Health and Professor of Genetics at Harvard Medical School. 'Given that our health is our most important asset, I'm excited to see technologies from my Harvard lab being translated into real-world applications to improve health.

“表观遗传学是我们了解衰老和疾病生物学驱动因素的最有力工具之一，”Tally Health联合创始人、哈佛医学院遗传学教授大卫·辛克莱博士说道。“鉴于健康是我们最重要的资产，我很高兴看到来自我哈佛实验室的技术正在被转化为实际应用，以改善健康。”

This combination brings together the scale of data, scientific rigor, and consumer reach needed to accelerate that impact.'.

这种组合汇集了加速这一影响所需的数据规模、科学严谨性和消费者覆盖范围。

About Infinite Epigenetics

关于无限表观遗传学

Infinite Epigenetics, through its subsidiary TruDiagnostic, is a leading epigenetic health data company and CLIA-certified laboratory specializing in epigenetic testing and research. With the world's largest private DNA methylation datasets, the company partners with biotech innovators, researchers, and healthcare organizations to translate epigenetic insights into actionable diagnostic and clinical applications.

通过其子公司TruDiagnostic，Infinite Epigenetics是一家领先的表观遗传健康数据公司，也是专注于表观遗传测试和研究的CLIA认证实验室。该公司拥有全球最大的私人DNA甲基化数据集，与生物技术革新者、研究人员和医疗保健机构合作，将表观遗传学见解转化为可操作的诊断和临床应用。

Its TruAge.

它的真实年龄。

TM

商标

and TruHealth

和TruHealth

TM

商标

epigenetic testing platforms provide advanced biological age and systems-level health insights to individuals and providers. For more information, visit

表观遗传学检测平台为个人和医疗提供者提供先进的生物学年龄和系统层面的健康洞察。欲了解更多信息，请访问

www.trudiagnostic.com

www.trudiagnostic.com

.

。

About Tally Health

关于Tally Health

®

®

Tally Health® is a biotechnology company dedicated to extending human healthspan through innovative, science-driven solutions. Founded by leaders in longevity science, Tally Health combines epigenetic testing with personalized interventions — including targeted supplements and lifestyle guidance — to help individuals take control of how they age.

Tally Health® 是一家生物技术公司，致力于通过创新的、科学驱动的解决方案延长人类健康寿命。该公司由长寿科学领域的领军人物创立，结合表观遗传学检测与个性化干预措施（包括针对性补充剂和生活方式指导），帮助个人掌控自己的衰老过程。

For more information, visit .

欲了解更多信息，请访问 。

www.tallyhealth.com

www.tallyhealth.com

.

。

Media Contact

媒体联系人

Factory PR

工厂公关

[email protected]

电子邮件地址

SOURCE TruDiagnostic

来源：TruDiagnostic

21

21

%

%

more press release views with

更多新闻稿浏览量与

Request a Demo

请求演示